Renal protection in chronic heart failure: focus on sacubitril/valsartan
R Pontremoli, C Borghi… - … Journal-Cardiovascular …, 2021 - academic.oup.com
… Sacubitril/valsartan reduced the risk of CV mortality compared to standard therapy with an
ACE-I in patients with heart failure … and tolerability of sacubitril/valsartan in patients with more …
ACE-I in patients with heart failure … and tolerability of sacubitril/valsartan in patients with more …
Sacubitril/valsartan: a review in chronic heart failure with reduced ejection fraction
PL McCormack - Drugs, 2016 - Springer
… Efficacy of sacubitril/valsartan in adult patients with chronic heart failure and reduced …
was death from cardiovascular causes or first hospitalization for worsening heart failure. CV …
was death from cardiovascular causes or first hospitalization for worsening heart failure. CV …
Effects of sacubitril/valsartan in patients with heart failure and chronic kidney disease: a meta-analysis
H Kang, J Zhang, X Zhang, G Qin, K Wang… - European journal of …, 2020 - Elsevier
… This meta-analysis evaluated the efficacy of sacubitril/valsartan compared to the RAS
inhibitors in patients with heart failure and CKD. It was found that sacubitril/valsartan significantly …
inhibitors in patients with heart failure and CKD. It was found that sacubitril/valsartan significantly …
What proportion of patients with chronic heart failure are eligible for sacubitril–valsartan?
P Pellicori, A Urbinati, P Shah… - … of heart failure, 2017 - Wiley Online Library
… The PARADIGM-HF trial showed that sacubitril–valsartan, an … patients with heart
failure (HF). It is uncertain what proportion of patients with HF would be eligible for sacubitril–valsartan …
failure (HF). It is uncertain what proportion of patients with HF would be eligible for sacubitril–valsartan …
Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction
AM Jackson, PS Jhund, IS Anand… - European heart …, 2021 - academic.oup.com
… heart failure and death from cardiovascular causes. We examined clinical endpoints and the
safety of sacubitril–valsartan … in blood pressure from the end of valsartan run-in to Weeks 4 …
safety of sacubitril–valsartan … in blood pressure from the end of valsartan run-in to Weeks 4 …
[HTML][HTML] Practical guidance on the use of sacubitril/valsartan for heart failure
… Initiation of sacubitril/valsartan in hospitalized patients with heart failure with reduced
ejection fraction after hemodynamic stabilization: primary results of the TRANSITION study. …
ejection fraction after hemodynamic stabilization: primary results of the TRANSITION study. …
Sacubitril/valsartan across the spectrum of ejection fraction in heart failure
SD Solomon, M Vaduganathan, B L. Claggett… - Circulation, 2020 - Am Heart Assoc
… The therapeutic effects of sacubitril/valsartan, compared with a renin-angiotensin-… ,
particularly for heart failure hospitalization, that appear to extend to patients with heart failure and …
particularly for heart failure hospitalization, that appear to extend to patients with heart failure and …
Benefits and adverse effects of sacubitril/valsartan in patients with chronic heart failure: A systematic review and meta‐analysis
E Charuel, T Menini, S Bedhomme… - Pharmacology …, 2021 - Wiley Online Library
… the benefits and adverse effects of sacubitril/valsartan in heart failure, with a focus on … )
comparing sacubitril/valsartan versus a reference drug, in heart failure patients with reduced (…
comparing sacubitril/valsartan versus a reference drug, in heart failure patients with reduced (…
Effect of treatment with sacubitril/valsartan in patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial
DL Mann, MM Givertz, JM Vader, RC Starling… - JAMA …, 2022 - jamanetwork.com
… and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic
heart failure … with the special contribution of the Heart Failure Association (HFA) of the ESC. …
heart failure … with the special contribution of the Heart Failure Association (HFA) of the ESC. …
Sacubitril/valsartan in heart failure: latest evidence and place in therapy
E Kaplinsky - Therapeutic advances in chronic disease, 2016 - journals.sagepub.com
… , patients with chronic heart failure (HF) remain at high risk for HF progression and death.
Sacubitril/valsartan (… (NEP) inhibitor (sacubitril) and an angiotensin II (Ang-II) receptor blocker (…
Sacubitril/valsartan (… (NEP) inhibitor (sacubitril) and an angiotensin II (Ang-II) receptor blocker (…
相关搜索
- sacubitril valsartan chronic kidney disease
- patients with chronic heart failure
- reduced ejection fraction chronic heart failure
- treatment of chronic heart failure
- renal protection chronic heart failure
- sacubitril valsartan systematic review
- paradigm hf chronic heart failure
- adverse effects chronic heart failure
- systolic blood pressure chronic heart failure
- efficacy and safety chronic heart failure
- meta analysis chronic heart failure
- sacubitril valsartan meta analysis
- sacubitril valsartan ejection fraction
- heart failure with preserved ejection fraction